Axsome Therapeutics
AXSM
$71.71
Share price
0.27%
Change (1 day)
2.28%
Change (1 year)
Categories
P/S ratio for Axsome Therapeutics (AXSM)
P/S ratio as of April 2024 (TTM): 12.6
According to Axsome Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.5596. At the end of 2023 the company had a P/S ratio of 13.9.
P/S ratio history for Axsome Therapeutics from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 13.9 | -79.21% |
| 2022 | 66.9 | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |